Title : Clopidogrel-drug interactions.

Pub. Date : 2011 Mar 15

PMID : 21392639






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Clopidogrel, a prodrug, requires hepatic cytochrome P450 (CYP) metabolic activation to produce the active metabolite that inhibits the platelet P2Y12 adenosine diphosphate (ADP) receptor, decreasing platelet activation and aggregation processes. Clopidogrel cytochrome P450 family 4 subfamily F member 3 Homo sapiens
2 Clopidogrel, a prodrug, requires hepatic cytochrome P450 (CYP) metabolic activation to produce the active metabolite that inhibits the platelet P2Y12 adenosine diphosphate (ADP) receptor, decreasing platelet activation and aggregation processes. Clopidogrel cytochrome P450 family 4 subfamily F member 3 Homo sapiens
3 Atorvastatin, omeprazole, and several other drugs have been shown in pharmacodynamic studies to competitively inhibit CYP activation of clopidogrel, reducing clopidogrel responsiveness. Clopidogrel cytochrome P450 family 4 subfamily F member 3 Homo sapiens
4 Atorvastatin, omeprazole, and several other drugs have been shown in pharmacodynamic studies to competitively inhibit CYP activation of clopidogrel, reducing clopidogrel responsiveness. Clopidogrel cytochrome P450 family 4 subfamily F member 3 Homo sapiens
5 Conversely, other agents increase clopidogrel responsiveness by inducing CYP activity. Clopidogrel cytochrome P450 family 4 subfamily F member 3 Homo sapiens